The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bms france; MSD Oncology; Novartis
Research Funding - MSD Oncology (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche/Genentech; Roche/Genentech
KEYNOTE-629: Health-related quality of life (HRQoL) with pembrolizumab (pembro) in patients (pts) with locally advanced (LA) or recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC).
 
Åse Bratland
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Sanofi
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
Eva Muñoz-Couselo
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Research Funding - Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Laurent Mortier
No Relationships to Disclose
 
Osama Roshdy
No Relationships to Disclose
 
Rene Gonzalez
No Relationships to Disclose
 
Jacob Schachter
Honoraria - Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Ana Maria Arance
Consulting or Advisory Role - Amgen; BMS; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Amgen; BMS; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; BMS; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
 
Florent Grange
Consulting or Advisory Role - MSD Oncology; Novartis
 
Nicolas Meyer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merckle GmbH; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech; Sun Pharma
Research Funding - Bristol-Myers Squibb (Inst); MSD Oncology (Inst)
 
Abhishek Jagdish Joshi
Honoraria - AstraZeneca; Ipsen; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Merck Sharp & Dohme; Novartis/Ipsen; Roche
 
Salem Billan
Honoraria - Bristol-Myers Squibb; Merck Serono; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; MSD
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche; Sanofi/Regeneron
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Jean-Jacques Grob
Consulting or Advisory Role - Amgen; BMS; Merck KGaA; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Roche; Roche/Genentech; Sanofi; Sun Pharma
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - BMS; MSD Oncology; Novartis; Pierre Fabre
 
Karthik Ramakrishnan
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Eric (Pingye) Zhang
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Burak Gumuscu
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Ramona F. Swaby
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Ralf Gutzmer
Honoraria - Almirall Hermal GmbH; Amgen; Bayer; Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron; Sun Pharma
Consulting or Advisory Role - 4SC; Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi; Sun Pharma
Research Funding - Amgen (Inst); Johnson & Johnson (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pierre Fabre; Roche; Sun Pharma